Historique de carrière de Cindy Wong
Anciens postes connus de Cindy Wong
Sociétés | Poste | Début | Fin |
---|---|---|---|
MOBERG PHARMA AB | Directeur Technique/Scientifique/R&D | 30/07/2020 | 01/01/2023 |
HANSA BIOPHARMA AB | Directeur/Membre du Conseil | 01/01/2012 | 11/05/2016 |
Independent Dir/Board Member | 01/01/2012 | 11/05/2016 | |
Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany. | Corporate Officer/Principal | - | - |
ONCOZENGE AB | Sales & Marketing | 01/01/2020 | - |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Cindy Wong
University of Adelaide | Doctorate Degree |
Statistiques
Internationale
Suède | 4 |
Australie | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
HANSA BIOPHARMA AB | Health Technology |
MOBERG PHARMA AB | Health Technology |
ONCOZENGE AB | Health Technology |
Entreprise privées | 2 |
---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany. | Health Technology |
- Bourse
- Insiders
- Cindy Wong
- Expérience